COMMUNIQUÉS West-GlobeNewswire

HealthEquity Reports Second Quarter Ended July 31, 2018 Financial Results
04/09/2018
Highlights of the second quarter include: Revenue of $71.1 million, an increase of 25% compared to Q2 FY18. Net income of $22.5 million, an increase of 33% compared to Q2 FY18. Net income per diluted share of $0.36 [...]
Aduro Biotech Presents Preclinical Data for BION-1301, a First-in-Class Antibody Targeting Human APRIL, at the 2018 European Congress of Immunology
04/09/2018
BERKELEY, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that preclinical data for its first-in-class anti-APRIL antibody BION-1301 was presented at the 5 th European [...]
BOAZ is handcrafting cannabis in Calgary
04/09/2018
Calgary media are invited to private tours of a new state-of-the-art cannabis production facility. CALGARY, Alberta, Sept. 04, 2018 (GLOBE NEWSWIRE) -- The grow lamps are on and cultivation begins in Calgary’s latest [...]
Project HOPE Celebrates 60 Years with Launch of New Brand Identity
04/09/2018
Millwood, VA, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Project HOPE today announced the launch of a new brand identity, logo, and website highlighting the global health and humanitarian relief organization’s unique mission [...]
Morningside Retirement Community Named Great Place to Work
04/09/2018
FULLERTON, CALIF., Sept. 04, 2018 (GLOBE NEWSWIRE) -- The Morningside continuing care retirement community in Fullerton, California, has been certified as a top workplace by the independent research and consulting firm [...]
Publication of eQUEST Study Results Demonstrate that eSight 3 is a Clinically Effective Device for the Visually Impaired
04/09/2018
Significant results to be published in September 2018 issue of Optometry and Vision Science TORONTO and LOS ANGELES, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Dr. Brian Mech, President and CEO of eSight, is proud to announce [...]
NANOBIOTIX half year results for the six months ended June 30, 2018
04/09/2018
Nanobiotix half year results for the six months ended June 30, 2018 Major milestones achieved with the success of Soft Tissue Sarcoma phase III clinical trial with first-in-class NBTXR3 product Overall expenses [...]
NANOBIOTIX : Résultats semestriels au 30 juin 2018
04/09/2018
Résultats semestriels au 30 juin 2018 Etapes majeures réalisées grâce au succès de l'essai clinique de phase III avec le produit premier de sa classe NBTXR3 Dépenses conformes aux prévisions de la Société Evènements [...]
Sanofi reaches civil settlement with US SEC
04/09/2018
Paris - September 4, 2018 - Sanofi has reached a civil settlement with the U.S. Securities and Exchange Commission (SEC) fully resolving the SEC's investigation into possible violations of the U.S. Foreign Corrupt [...]
Sanofi conclut un accord avec la « Securities and Exchange Commission » américaine
04/09/2018
Sanofi conclut un accord avec la « Securities and Exchange Commission » américaine Paris - Le 4 septembre 2018 - Sanofi a conclu un accord avec l'Autorité des marchés financiers des États-Unis (US Securities and [...]
CORRECTION -- BioCryst Reports Positive Results Across Multiple Endpoints in ZENITH-1 Trial of Oral BCX7353 as Acute Therapy for Hereditary Angioedema (HAE) Attacks
04/09/2018
—Safety and efficacy data support advancement of 750 mg dose as first oral therapy for acute HAE attacks— In a release issued under the same headline earlier today by BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), please [...]
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors
04/09/2018
Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT ® STR bioreactors and Repligen’s XCell™ ATF cell retention control technology Customers to benefit from simplified, scalable solutions for [...]
Infant Bacterial Therapeutics publishes prospectus in connection with the list change to Nasdaq Stockholm
04/09/2018
On August 30, 2018, Infant Bacterial Therapeutics AB (publ) (”IBT” or the ”Company”) announced that Nasdaq Stockholm’s Listing Committee had approved the admission of the Company’s shares of series B for trading on [...]
Announcement regarding the election of the Chairperson and deputy of the Council of JSC “Olainfarm”, as well as the changes in JSC “Olainfarm” Management Board
04/09/2018
JSC Olainfarm hereby informs about the following decisions taken by its Supervisory Council on September 4, 2018: Elect Pavels Rebenoks to be the Chairman of the Council of JSC “Olainfarm”; Elect Irina Maligina to be [...]
Collegium Announces Scientific Presentations at PAINWeek 2018 Meeting
04/09/2018
STOUGHTON, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it has supported the following poster presentations on tapentadol (Nucynta® and Nucynta® ER), at [...]
RESOLUTIONS of the Extraordinary General Meeting of Shareholders held on September 04th, 2018
04/09/2018
Amendment of Statutes . Decision: Reject draft decision published by JSC “Olainfarm” Management Board. Voting results: decision is taken with the required majority of votes. Supplementing Agenda with additional items. [...]
Key Biologics and Blood Centers of America Partner to Advance Cell Therapy and Regenerative Medicine
04/09/2018
Collaboration aims to open up access to important new therapies MEMPHIS, Tenn. and WEST WARWICK, R.I., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Key Biologics LLC and Blood Centers of America (BCA) today announced an agreement [...]
CORRECTING and REPLACING -- Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors
04/09/2018
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today by Ziopharm Oncology , Inc. (Nasdaq:ZIOP), please note the Company's upcoming annual meeting of stockholders is being held Sept. 18 rather [...]
Radius Health Appoints Dr. Charles Morris as Chief Medical Officer
04/09/2018
WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) today announced the appointment of Dr. Charles Morris as Chief Medical Officer. Dr. Morris will oversee [...]

Pages